selected scholarly activity
-
academic article
- Prevention of acute and delayed chemotherapy‐induced nausea and vomiting in pediatric cancer patients: A clinical practice guideline. Pediatric Blood and Cancer Medical and Pediatric Oncology. 69:e30001. 2022
- Temporal clustering of neuroblastic tumours in children and young adults from Ontario, Canada. Environmental Health: A Global Access Science Source. 21:30. 2022
- Interventions for the prevention of acute phase chemotherapy-induced nausea and vomiting in adult and pediatric patients: a systematic review and meta-analysis. Supportive Care in Cancer. 30:8855-8869. 2022
- Creating and adapting an infection management care pathway in pediatric oncology. Supportive Care in Cancer. 30:7923-7934. 2022
- Healthcare utilization and costs associated with acute lymphoblastic leukemia in children with and without Down syndrome. Pediatric Blood and Cancer Medical and Pediatric Oncology. 69:e29829. 2022
- Creating Video-Based Education Modules for Parents of Newly Diagnosed Pediatric Patients With Cancer. Cancer Nursing. 45:E428-E435. 2022
- KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors: Description of Clinical Research Protocol of the KINDEST-CCS Study. Canadian Journal of Kidney Health and Disease. 9:205435812211301-205435812211301. 2022
- Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes. JAMA Oncology. 7:1806-1806. 2021
- Incidence of childhood cancer in Canada during the COVID-19 pandemic. CMAJ. 193:E1798-E1806. 2021
- Blinatumomab Is Cost-Effective Compared to Standard Chemotherapy for Children with High Risk Relapses of Acute Lymphoblastic Leukemia: A Cost-Effectiveness Analysis Using Population-Based Healthcare Data. Blood. 138:565-565. 2021
- Rates and Predictors of Visits to Primary Care Physicians during and after Treatment of Childhood Acute Lymphoblastic Leukemia: A Population-Based Cohort Study. Blood. 138:839-839. 2021
- Identifying clinical practice guidelines for symptom control in pediatric oncology. Supportive Care in Cancer. 29:7049-7055. 2021
- Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors. Journal of Clinical Oncology. 39:3207-3216. 2021
- Phase‐specific risks of outpatient visits, emergency visits, and hospitalizations during Children's Oncology Group‐based treatment for childhood acute lymphoblastic leukemia: A population‐based study. Pediatric Blood and Cancer Medical and Pediatric Oncology. 68:e29141. 2021
- Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update. European Journal of Cancer. 154:92-101. 2021
- Health care utilisation and costs associated with different treatment protocols for newly diagnosed childhood acute lymphoblastic leukaemia: A population-based study in Ontario, Canada. European Journal of Cancer. 151:126-135. 2021
- Diagnostic discrepancies between antemortem clinical diagnosis and autopsy findings in pediatric cancer patients. Virchows Archiv. 478:1179-1185. 2021
- Feeling scared or worried self-report in children receiving cancer treatments using the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 29:3137-3144. 2021
- Predictors of clinical trial enrollment and impact on outcome in children and adolescents with acute lymphoblastic leukemia: A population based study.. Journal of Clinical Oncology. 39:7031-7031. 2021
- Prevention and treatment of anticipatory chemotherapy‐induced nausea and vomiting in pediatric cancer patients and hematopoietic stem cell recipients: Clinical practice guideline update. Pediatric Blood and Cancer Medical and Pediatric Oncology. 68:e28947. 2021
- A Population-Based Study of COVID-19 Infection Among Childhood Cancer Survivors. Frontiers in Medicine. 8:718316. 2021
- Radiological Assessment and Outcome of Local Disease Progression after Neoadjuvant Chemotherapy in Children and Adolescents with Localized Osteosarcoma. Journal of Clinical Medicine Journal of Clinical Medicine Journal of Clinical Medicine. 9:4070-4070. 2020
- Healthcare Utilization and Costs Associated with Different Treatment Protocols for Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Population-Based Study. Blood. 136:46-47. 2020
- Effect of different conditioning regimens on survival and engraftment for children with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoeitic stem cell transplantation: A single institution experience. Pediatric Blood and Cancer Medical and Pediatric Oncology. 67:e28477. 2020
- Assessing Parents’ Needs in Using Phone Applications to Improve Medication Adherence in an Outpatient Pediatric Oncology Clinic. Journal of Pediatric Hematology/Oncology. 42:e277-e280. 2020
- Recommendations for medical care in the pediatric oncology camp setting: Consensus statements based on Delphi methodology. Pediatric Blood and Cancer Medical and Pediatric Oncology. 67:e28107. 2020
- Severely bothersome fatigue in children and adolescents with cancer and hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 27:2665-2671. 2019
- Taste changes in children with cancer and hematopoietic stem cell transplant recipients. Supportive Care in Cancer. 27:2247-2254. 2019
- Classification of the acute emetogenicity of chemotherapy in pediatric patients: A clinical practice guideline. Pediatric Blood and Cancer Medical and Pediatric Oncology. 66:e27646-e27646. 2019
- Validation of the Proxy Version of Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. Journal of Pain and Symptom Management. 56:107-112. 2018
- Validation of the Symptom Screening in Pediatrics Tool in Children Receiving Cancer Treatments. Journal of the National Cancer Institute. 110:661-668. 2018
- Relationship between cyclosporine area-under-the curve and acute graft versus host disease in pediatric patients undergoing hematopoietic stem cell transplant: A prospective, multicenter study. Pediatric Hematology and Oncology. 35:288-296. 2018
- Describing symptoms using the Symptom Screening in Pediatrics Tool in hospitalized children with cancer and hematopoietic stem cell transplant recipients. Cancer Medicine. 7:1750-1755. 2018
- Pediatric oncology clinical trial participation where the geography is vast: Development of a clinical research system for tertiary and satellite centers in Ontario, Canada. Pediatric Blood and Cancer Medical and Pediatric Oncology. 65:e26901-e26901. 2018
- Evaluation of the electronic self-report Symptom Screening in Pediatrics Tool (SSPedi). BMJ Supportive and Palliative Care. 8:110-116. 2018
- Treatment-related mortality in newly diagnosed pediatric cancer: a population-based analysis. Cancer Medicine. 7:707-715. 2018
- Olanzapine for prevention of chemotherapy-induced nausea and vomiting in children and adolescents: a multi-center, feasibility study. Supportive Care in Cancer. 26:549-555. 2018
- Guideline for the prevention of acute chemotherapy-induced nausea and vomiting in pediatric cancer patients: A focused update. Pediatric Blood and Cancer Medical and Pediatric Oncology. 64:e26542-e26542. 2017
- Guideline for the prevention of oral and oropharyngeal mucositis in children receiving treatment for cancer or undergoing haematopoietic stem cell transplantation. BMJ Supportive and Palliative Care. 7:7-16. 2017
- Evaluation of treatment-related mortality among paediatric cancer deaths: a population based analysis. British Journal of Cancer. 116:540-545. 2017
- Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer. Pediatric Blood and Cancer Medical and Pediatric Oncology. 63:1144-1151. 2016
- Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group. Pediatric Blood and Cancer Medical and Pediatric Oncology. 63:973-982. 2016
- Methodological issues identified during cognitive interviews in the development of a pediatric cancer symptom screening tool. Psycho-Oncology. 25:349-353. 2016
- Classification of treatment-related mortality in children with cancer: a systematic assessment. The Lancet Oncology. 16:e604-e610. 2015
- IV administration of Erwinia-derived asparaginase in pediatric patients with acute lymphoblastic leukemia: Single-centre case series. Canadian Journal of Hospital Pharmacy. 68:481-484. 2015
- Predictors of diagnostic interval and associations with outcome in acute lymphoblastic leukemia. Pediatric Blood and Cancer Medical and Pediatric Oncology. 62:957-963. 2015
- Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review. BMC Cancer. 14:612. 2014
- Refinement of the Symptom Screening in Pediatrics Tool (SSPedi). British Journal of Cancer. 111:1262-1268. 2014
- Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatric Blood and Cancer Medical and Pediatric Oncology. 61:1506-1512. 2014
- Erratum to: Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 22:77-78. 2014
- Initial development of the Symptom Screening in Pediatrics Tool (SSPedi). Supportive Care in Cancer. 22:71-75. 2014
- Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastoma. Pediatric Blood and Cancer Medical and Pediatric Oncology. 60:1636-1641. 2013
- Prediction of Area under the Cyclosporine Concentration Versus Time Curve in Children Undergoing Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 19:418-423. 2013
- The Role of Tc-99m-DTPA Nuclear Medicine GFR Studies in Pediatric Solid Tumor Patients. Journal of Pediatric Hematology/Oncology. 35:108-111. 2013
- Do children with central venous line (CVL) dysfunction have increased risk of symptomatic thromboembolism compared to those without CVL-dysfunction, while on cancer therapy?. BMC Cancer. 12:314. 2012
- Relapse of Wilms' Tumor 13 Years After Original Diagnosis. Journal of Pediatric Hematology/Oncology. 27:293-294. 2005
-
chapter
- B Cell Leukemia and Lymphoma. 279-286. 2016
-
conference paper
- Addressing adherence to guidelines on prevention of acute chemotherapy‐induced nausea and vomiting in pediatric patients. Pediatric Blood and Cancer Medical and Pediatric Oncology. e30210. 2023
- CREATING AND ADAPTING AN INFECTION MANAGEMENT CARE PATHWAY IN PEDIATRIC ONCOLOGY. Pediatric Blood and Cancer Medical and Pediatric Oncology. 2022
- PREDICTORS OF PRE-MAINTENANCE DELAYS DURING THERAPY AND ASSOCIATIONS WITH OUTCOME AMONG CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED STUDY. Pediatric Blood and Cancer Medical and Pediatric Oncology. 2022
- Development and Validation of a Childhood Acute Lymphoblastic Leukemia Policy Model Constructed Using Real World Population-Based Data. Pediatric Blood and Cancer Medical and Pediatric Oncology. S111-S111. 2021
- Healthcare Utilization and Costs Associated with Acute Lymphoblastic Leukemia (ALL) in Children with and without Down Syndrome (DS): A Population-Based Study. Pediatric Blood and Cancer Medical and Pediatric Oncology. S186-S187. 2021
- The First Wave of The Covid-19 Pandemic Did Not Affect Childhood Cancer Incidence In Canada: A Report from Cyp-C. Pediatric Blood and Cancer Medical and Pediatric Oncology. S136-S137. 2021
- PHASE-SPECIFIC RISKS OF EMERGENCY VISITS AND HOSPITALIZATIONS DURING COG-BASED ALL TREATMENT. Pediatric Blood and Cancer Medical and Pediatric Oncology. S50-S50. 2021
- Performance of an Ehealth Decision Support Tool (MIPOGG) for Identifying Children With Constitutional Mismatch Repair Deficiency, DICER1 Syndrome, Gorlin Syndrome and Li-Fraumeni Syndrome. Pediatric Blood and Cancer Medical and Pediatric Oncology. S218-S218. 2020
- The Cancer in Young People in Canada Data Tool: An Interactive Display of the Incidence, Survival, and Recurrence of Childhood Cancer in Canada, 2001-2016. Pediatric Blood and Cancer Medical and Pediatric Oncology. S131-S131. 2020
- Performance of an E-Health Decision-Support Tool for Identifying Cancer Predisposition Syndromes in Canadian Pediatric Oncology Centres. Pediatric Blood and Cancer Medical and Pediatric Oncology. S72-S73. 2019
- COMPARISON OF HEMATOPOIETIC STEM CELL TRANSPLANTATION CONDITIONING REGIMENS FOR PEDIATRIC HLH. Pediatric Blood and Cancer Medical and Pediatric Oncology. 2019
- HIGH VS. LOW-INTENSITY BRIDGING CHEMOTHERAPY WHEN AWAITING CAR-T THERAPY: A POPULATION- BASED STUDY. Pediatric Blood and Cancer Medical and Pediatric Oncology. 2019
- IMPACT OF CHILDHOOD CANCER DRUG WASTAGE ON PEDIATRIC ONCOLOGY PROGRAMS IN ONTARIO, CANADA. Pediatric Blood and Cancer Medical and Pediatric Oncology. 2019
- High Vs. Low-Intensity Bridging Chemotherapy in Children with Acute Lymphoblastic Leukemia Awaiting Chimeric Antigen Receptor T-Cell Therapy: A Population-Based Study from Ontario, Canada. Blood. 1410-1410. 2018
- Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013. Blood. 4698-4698. 2018
- Ongoing recurrent hospitalization, malignancy, and mortality among survivors of childhood hematopoietic stem cell transplantation performed for non-malignant indications. Bone Marrow Transplantation. 125-126. 2018
- Design and Implementation of Comprehensive Inpatient and Outpatient CPOE in a Paediatric Oncology Centre. Pediatric Blood and Cancer Medical and Pediatric Oncology. S221-S221. 2016
- Olanzapine for Chemotherapy-Induced Nausea and Vomiting (CINV) Prophylaxis in Children: A Multi-Centre Feasibility Study. Pediatric Blood and Cancer Medical and Pediatric Oncology. S278-S278. 2016
- LACK OF TREATMENT-RELATED MORTALITY DEFINITIONS IN STUDIES OF CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH LYMPHOMAS, SOLID TUMORS AND BRAIN TUMORS: A SYSTEMATIC REVIEW. Pediatric Blood and Cancer Medical and Pediatric Oncology. S403-S403. 2014
- PREDICTORS OF CANCER DIAGNOSTIC INTERVALS AND ASSOCIATIONS WITH OUTCOME IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: A POPULATION-BASED COHORT STUDY USING HEALTH SERVICES DATA. Pediatric Blood and Cancer Medical and Pediatric Oncology. S81-S81. 2014
- INITIAL DEVELOPMENT OF THE SYMPTOM SCREENING IN PEDIATRIC TOOL (SSPEDI). Pediatric Blood and Cancer Medical and Pediatric Oncology. 169-169. 2013
- PEDIATRIC ONCOLOGY GROUP OF ONTARIO (POGO) GUIDELINES FOR PREVENTION OF ANTINEOPLASTIC-INDUCED NAUSEA AND VOMITING (AINV) IN CHILDREN: ACUTE AND ANTICIPATORY AINV. Pediatric Blood and Cancer Medical and Pediatric Oncology. 27-27. 2013
- Cyclosporine Area Under the Curve in Children Undergoing Haematopoietic Stem Cell Transplantation: Limited Sampling Strategy at Steady-State. Biology of Blood and Marrow Transplantation. S308-S308. 2012
- DO NUCLEAR MEDICINE GFR STUDIES CONTRIBUTE TO THERAPEUTIC DECISION MAKING IN PEDIATRIC ONCOLOGY PATIENTS RECEIVING CHEMOTHERAPY?. Pediatric Blood and Cancer Medical and Pediatric Oncology. 937-938. 2011
- CD56 EXPRESSION AS A PROGNOSTIC INDICATOR IN PEDIATRIC AML: A SINGLE CENTRE REVIEW. Pediatric Blood and Cancer Medical and Pediatric Oncology. 828-828. 2010
- ACINIC CELL CARCINOMA: CUT IT OUT ..... THEN WHAT?. Pediatric Blood and Cancer Medical and Pediatric Oncology. 738-738. 2009